Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 9.85 Billion JPY | 26.37% |
| 2022 | 7.8 Billion JPY | 42.06% |
| 2021 | 5.49 Billion JPY | 9.29% |
| 2020 | 5.02 Billion JPY | -6.73% |
| 2019 | 5.38 Billion JPY | 0.74% |
| 2018 | 5.34 Billion JPY | -9.38% |
| 2017 | 5.9 Billion JPY | -4.08% |
| 2016 | 6.15 Billion JPY | -6.13% |
| 2015 | 6.55 Billion JPY | -0.52% |
| 2014 | 6.58 Billion JPY | 1.8% |
| 2013 | 6.47 Billion JPY | 5.84% |
| 2012 | 6.11 Billion JPY | 9.92% |
| 2011 | 5.56 Billion JPY | 4.93% |
| 2010 | 5.3 Billion JPY | 3.44% |
| 2009 | 5.12 Billion JPY | -7.21% |
| 2008 | 5.52 Billion JPY | 7.32% |
| 2007 | 5.14 Billion JPY | 6.51% |
| 2006 | 4.83 Billion JPY | 20.7% |
| 2005 | 4 Billion JPY | 6.5% |
| 2004 | 3.75 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.16 Billion JPY | 1.64% |
| 2023 Q1 | 1.96 Billion JPY | -33.07% |
| 2023 Q2 | 2.03 Billion JPY | 3.58% |
| 2023 Q3 | 2.99 Billion JPY | 47.16% |
| 2023 Q4 | 3.11 Billion JPY | 4.04% |
| 2023 FY | 9.85 Billion JPY | 26.37% |
| 2022 Q1 | 1.34 Billion JPY | -24.28% |
| 2022 Q3 | 1.77 Billion JPY | 1.18% |
| 2022 Q4 | 2.93 Billion JPY | 65.89% |
| 2022 FY | 7.8 Billion JPY | 42.06% |
| 2022 Q2 | 1.75 Billion JPY | 30.56% |
| 2021 Q2 | 1.28 Billion JPY | 19.52% |
| 2021 FY | 5.49 Billion JPY | 9.29% |
| 2021 Q1 | 1.07 Billion JPY | -34.1% |
| 2021 Q3 | 1.36 Billion JPY | 7.02% |
| 2021 Q4 | 1.77 Billion JPY | 29.27% |
| 2020 Q1 | 1.13 Billion JPY | -34.04% |
| 2020 FY | 5.02 Billion JPY | -6.73% |
| 2020 Q4 | 1.62 Billion JPY | 43.48% |
| 2020 Q2 | 1.13 Billion JPY | -0.42% |
| 2020 Q3 | 1.13 Billion JPY | 0.14% |
| 2019 Q1 | 1.21 Billion JPY | 7.59% |
| 2019 Q2 | 1.2 Billion JPY | -0.56% |
| 2019 Q3 | 1.24 Billion JPY | 3.75% |
| 2019 FY | 5.38 Billion JPY | 0.74% |
| 2019 Q4 | 1.72 Billion JPY | 37.81% |
| 2018 Q2 | 1.68 Billion JPY | 18.56% |
| 2018 Q3 | 1.11 Billion JPY | -33.67% |
| 2018 Q4 | 1.12 Billion JPY | 0.77% |
| 2018 FY | 5.34 Billion JPY | -9.38% |
| 2018 Q1 | 1.42 Billion JPY | -7.53% |
| 2017 Q4 | 1.53 Billion JPY | 12.0% |
| 2017 Q3 | 1.37 Billion JPY | -5.37% |
| 2017 Q2 | 1.44 Billion JPY | -6.12% |
| 2017 FY | 5.9 Billion JPY | -4.08% |
| 2017 Q1 | 1.54 Billion JPY | -1.5% |
| 2016 FY | 6.15 Billion JPY | -6.13% |
| 2016 Q2 | 1.52 Billion JPY | -4.57% |
| 2016 Q3 | 1.46 Billion JPY | -3.53% |
| 2016 Q4 | 1.56 Billion JPY | 6.76% |
| 2016 Q1 | 1.59 Billion JPY | -2.15% |
| 2015 Q3 | 1.59 Billion JPY | -2.31% |
| 2015 Q2 | 1.63 Billion JPY | -4.1% |
| 2015 Q1 | 1.7 Billion JPY | 4.01% |
| 2015 FY | 6.55 Billion JPY | -0.52% |
| 2015 Q4 | 1.62 Billion JPY | 2.31% |
| 2014 Q4 | 1.63 Billion JPY | 2.34% |
| 2014 FY | 6.58 Billion JPY | 1.8% |
| 2014 Q3 | 1.59 Billion JPY | -0.66% |
| 2014 Q2 | 1.6 Billion JPY | -7.98% |
| 2014 Q1 | 1.74 Billion JPY | 5.13% |
| 2013 Q2 | 1.68 Billion JPY | 8.05% |
| 2013 Q1 | 1.55 Billion JPY | -7.77% |
| 2013 Q3 | 1.57 Billion JPY | -6.43% |
| 2013 FY | 6.47 Billion JPY | 5.84% |
| 2013 Q4 | 1.66 Billion JPY | 5.69% |
| 2012 Q2 | 1.5 Billion JPY | 1.25% |
| 2012 Q3 | 1.44 Billion JPY | -4.0% |
| 2012 FY | 6.11 Billion JPY | 9.92% |
| 2012 Q1 | 1.48 Billion JPY | 71.77% |
| 2012 Q4 | 1.68 Billion JPY | 16.97% |
| 2011 FY | 5.56 Billion JPY | 4.93% |
| 2011 Q4 | 863.78 Million JPY | -45.58% |
| 2011 Q3 | 1.58 Billion JPY | 2.47% |
| 2011 Q2 | 1.54 Billion JPY | -0.89% |
| 2011 Q1 | 1.56 Billion JPY | 116.87% |
| 2010 Q4 | 720.7 Million JPY | -52.67% |
| 2010 Q3 | 1.52 Billion JPY | -1.04% |
| 2010 Q1 | 1.51 Billion JPY | 97.34% |
| 2010 FY | 5.3 Billion JPY | 3.44% |
| 2010 Q2 | 1.53 Billion JPY | 1.28% |
| 2009 Q3 | 1.41 Billion JPY | -5.16% |
| 2009 Q4 | 769.86 Million JPY | -45.63% |
| 2009 FY | 5.12 Billion JPY | -7.21% |
| 2009 Q1 | 1.44 Billion JPY | 59.7% |
| 2009 Q2 | 1.49 Billion JPY | 3.23% |
| 2008 Q3 | 1.53 Billion JPY | 2.56% |
| 2008 FY | 5.52 Billion JPY | 7.32% |
| 2008 Q4 | 905.62 Million JPY | -41.14% |
| 2008 Q2 | 1.5 Billion JPY | 0.0% |
| 2007 FY | 5.14 Billion JPY | 6.51% |
| 2006 FY | 4.83 Billion JPY | 20.7% |
| 2005 FY | 4 Billion JPY | 6.5% |
| 2004 FY | 3.75 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| DNA Chip Research Inc. | 324.19 Million JPY | -2941.014% |
| Cosmo Bio Company,Limited | 2.73 Billion JPY | -260.998% |
| H.U. Group Holdings, Inc. | 67.27 Billion JPY | 85.346% |
| FALCO HOLDINGS Co., Ltd. | 10.77 Billion JPY | 8.469% |
| BML, Inc. | 36.46 Billion JPY | 72.961% |
| Human Metabolome Technologies, Inc. | 639.4 Million JPY | -1441.886% |
| Precision System Science Co., Ltd. | 1.9 Billion JPY | -417.085% |